Minoo, Japan

Yoshimi Kawamura


Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Mino, JP (1981 - 1992)
  • Osaka, JP (1984 - 1995)
  • Minoo, JP (1991 - 1999)
  • Osaka-fu, JP (2000)

Company Filing History:


Years Active: 1981-2000

Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yoshimi Kawamura

Introduction: Yoshimi Kawamura, a prominent inventor based in Minoo, Japan, has made significant contributions to the field of pharmaceuticals, specifically in the development of antibiotics and antiviral compounds. With a remarkable portfolio of 18 patents, Kawamura stands out as a leading figure in her industry.

Latest Patents: Among her noteworthy inventions are two recent patents focused on antibiotics and antiviral agents. The first, titled "Antibiotic Stalobacins," showcases novel antibiotic stalobacins H-1 and I-1, which exhibit excellent efficacy against Gram-positive bacteria, as detailed in accompanying physico-chemical properties. The second patent involves "Sequiterpene Derivatives Having Antiviral Activity," further illustrating her innovative work in combating microbial threats.

Career Highlights: Kawamura has had a distinguished career working with notable companies, including Shionogi & Company Limited and Shionogi Seiyaku Kabushiki Kaisha. Her expertise in pharmaceutical research and development has positioned her as a key contributor to several groundbreaking projects within these organizations.

Collaborations: Throughout her career, Yoshimi Kawamura has collaborated with several accomplished individuals, including renowned coworkers Koichi Matsumoto and Tadashi Yoshida. These collaborations have fostered a synergistic approach to innovation, enabling the development of effective solutions in medicine.

Conclusion: Yoshimi Kawamura's significant achievements and ongoing contributions to the field of pharmaceuticals reflect her dedication to innovation. Her work not only demonstrates her inventive spirit but also her commitment to advancing healthcare through the development of effective antibiotics and antiviral drugs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…